A Study Evaluating TRIV-509 in Atopic Dermatitis

Clinical trial NCT07167758 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07167758
Sponsor: Triveni Bio
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2025-08-26
Primary completion: 2026-10-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.